BEIJING XUANYI PHARMASCIENCES CO LTD has a total of 30 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), Taiwan and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are FUJIREBIO DIAGNOSTICS INC, APROGEN KIC INC and LIU DONGFANG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Taiwan | 4 | |
#3 | China | 3 | |
#4 | Australia | 2 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Israel | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Singapore | 2 | |
#11 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Sugars | |
#6 | Analysing materials | |
#7 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Song Yuntao | 25 |
#2 | Chen Xiaoqi | 12 |
#3 | Ding Yi | 11 |
#4 | Dong Chen | 10 |
#5 | Szu Ping Hui | 9 |
#6 | Lippincott John | 9 |
#7 | Li Anrong | 8 |
#8 | Li Zhiwei | 8 |
#9 | Li Hui | 3 |
#10 | Zhou Haiping | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021067458A1 | Protein-macromolecule conjugates and methods of use thereof | |
WO2021047599A1 | Humanized anti-claudin 18.2 (cldn18.2) antibodies | |
WO2020219896A1 | Cd80 variant proteins and uses thereof | |
TW202043204A | Tetrazolone substituted steroids and use thereof | |
CN112166123A | Anti-claudin 18.2 antibodies | |
SG11202001847WA | Cyclic di-nucleotides as stimulator of interferon genes modulators | |
CN111315379A | CDK4/6 inhibitor and application thereof |